Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brough

Showing results (791-800 of 871) with videos related to

Pageof 88
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 7, 2025
BSACI guidance for the implementation of Palforzia® peanut oral immunotherapy in the United Kingdom: A Delphi consensus studyTom Marrs, Nandinee Patel, Sarah Burrell, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 22, 2024
Skin as the target for allergy prevention and treatmentAndreina Marques-Mejias, Irene Bartha, Christina E Ciaccio, et al.
NEJM Evidence|May 28, 2024
Follow-up to Adolescence after Early Peanut Introduction for Allergy PreventionGeorge Du Toit, Michelle F Huffaker, Suzana Radulovic, et al.
Nature Cell Biology|October 2, 2023
Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasisFangfei Qu, Siqi C Brough, Wojciech Michno, et al.
Molecular Cancer Therapeutics|July 2, 2016
Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with DasatinibRowan E Miller, Rachel Brough, Ilirjana Bajrami, et al.
Cell Chemical Biology|September 26, 2017
Boron-Based Inhibitors of the NLRP3 InflammasomeAlex G Baldwin, Jack Rivers-Auty, Michael J D Daniels, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2025
PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancerCharalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.
Nature Communications|May 12, 2018
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistanceStephen J Pettitt, Dragomir B Krastev, Inger Brandsma, et al.
JAMA Dermatology|April 9, 2020
Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell TransplantsJeffrey F Scott, Kevin R Brough, Konstantin V Grigoryan, et al.
Cancer Research|October 23, 2022
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor ResistanceMarta J Llorca-Cardenosa, Lauren I Aronson, Dragomir B Krastev, et al.
Pageof 88

Showing results (791-800 of 871) with videos related to

Sort By:
Pageof 88
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 7, 2025
BSACI guidance for the implementation of Palforzia® peanut oral immunotherapy in the United Kingdom: A Delphi consensus studyTom Marrs, Nandinee Patel, Sarah Burrell, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 22, 2024
Skin as the target for allergy prevention and treatmentAndreina Marques-Mejias, Irene Bartha, Christina E Ciaccio, et al.
NEJM Evidence|May 28, 2024
Follow-up to Adolescence after Early Peanut Introduction for Allergy PreventionGeorge Du Toit, Michelle F Huffaker, Suzana Radulovic, et al.
Nature Cell Biology|October 2, 2023
Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasisFangfei Qu, Siqi C Brough, Wojciech Michno, et al.
Molecular Cancer Therapeutics|July 2, 2016
Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with DasatinibRowan E Miller, Rachel Brough, Ilirjana Bajrami, et al.
Cell Chemical Biology|September 26, 2017
Boron-Based Inhibitors of the NLRP3 InflammasomeAlex G Baldwin, Jack Rivers-Auty, Michael J D Daniels, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2025
PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancerCharalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.
Nature Communications|May 12, 2018
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistanceStephen J Pettitt, Dragomir B Krastev, Inger Brandsma, et al.
JAMA Dermatology|April 9, 2020
Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell TransplantsJeffrey F Scott, Kevin R Brough, Konstantin V Grigoryan, et al.
Cancer Research|October 23, 2022
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor ResistanceMarta J Llorca-Cardenosa, Lauren I Aronson, Dragomir B Krastev, et al.
Pageof 88